Media-OutReach Newswire Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease
Media-OutReach Newswire Zhejiang-based Global New Material International Expands Overseas: Hangzhou Becomes a New Starting Point for the China-German Industrial Synergies